Dash Bio

Dash Bio is a company building an infrastructure for drug development. From its funding announcement.

$30M Series ARaised 2 months agoWaltham, USABiotech & PharmaUSA
Visit website →

In their own words

What Dash Bio says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "company building an infrastructure for drug development". Source

Market expansionProductCommercial growthManufacturing and scale

Public signal Read from the company's own description of what the funding supports.

Why now

Where Dash Bio is today

Dash Bio announced a Series A round of $30M on 3 August 2026, led by Oak HC/FT.

Latest round
Series A
Amount
$30M
Announced
3 August 2026
Headquarters
Waltham, USA
Sector
Biotech & Pharma
Investors
Also participating
Freestyle Capital, Swift Ventures
Relevant leadership
Not stated

Momentum AfterRaise intelligence

AfterRaise Score

59
Steady growth
1 funding signal in the last 90 days
Funding recency
28/40
announced within the last 90 days
Round scale
16/25
round size relative to the market
Funding stage
15/20
Series A
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 3 August 2026
    $30M Series A
    Led by Oak HC/FT.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • New market entry
  • First local hires in the new market
  • Local entity and legal setup
  • Product launches and new tiers

Opportunities this could create

  • CMC and manufacturing
  • Quality systems
  • Scientific hiring
  • Licensing and BD partnerships
  • Market-entry advisers

Based on the Biotech & Pharma sector, a Series A round and the priorities the company itself set out. Not a statement of fact.

Medium momentum5 connected signals
  • 3 August 2026$30M Series A announced
  • 3 August 2026Stated priority: market expansion
  • 3 August 2026Stated priority: product
  • 3 August 2026Stated priority: commercial growth
  • 3 August 2026Stated priority: manufacturing and scale

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What Dash Bio is open to

Not yet specified

Dash Bio has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with Dash Bio

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at Dash Bio?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: the roles and projects you have open and who leads the team. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Biotech & Pharma companies

See the sector